ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,118.27
1.07%
Dow Jones
38,642.46
1.09%
US Dollar vs MXN
17.01964
0.28%
Brent Oil
83.325
-0.36%
Bitcoin
61,566.67
4.14%
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Blueprint Medicines Corporation (BPMC)

  7. Blueprint Medicines Corporation (BPMC) Noticias

BPMC Blueprint Medicines Corporation

107.00
0.00 (0.00%)
Última actualización: 10:20:33
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Blueprint Medicines Corporation BPMC NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
0.00 0.00% 107.00 10:20:33
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
109.82 106.7901 110.93 107.00
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
02/5/202406:00PRNUSBlueprint Medicines Reports Strong First Quarter 2024..
18/4/202407:00PRNUSBlueprint Medicines to Report First Quarter 2024 Financial..
11/4/202407:00PRNUSBlueprint Medicines to Host Webcast and Conference Call..
04/4/202415:01PRNUSBlueprint Medicines Announces Inducement Grants Under Nasdaq..
11/3/202417:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/3/202417:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/3/202417:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/3/202417:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/3/202417:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/3/202417:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/3/202417:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/3/202417:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/3/202417:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202415:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202415:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202415:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202415:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202415:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202415:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202415:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202415:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202415:01PRNUSBlueprint Medicines Announces Inducement Grants Under Nasdaq..
06/3/202409:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202417:19EDGAR2Form 144 - Report of proposed sale of securities
01/3/202414:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202415:03EDGAR2Form 144 - Report of proposed sale of securities
23/2/202407:00PRNUSBlueprint Medicines Highlights AYVAKIT® (avapritinib)..
22/2/202407:20EDGAR2Form 8-K - Current report
16/2/202415:40EDGAR2Form S-8 - Securities to be offered to employees in employee..
15/2/202416:26EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
15/2/202406:05EDGAR2Form 8-K - Current report
15/2/202406:00PRNUSBlueprint Medicines Reports Fourth Quarter and Full Year..
14/2/202417:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/2/202415:01PRNUSBlueprint Medicines Announces Inducement Grants Under Nasdaq..
01/2/202407:00PRNUSBlueprint Medicines to Report Fourth Quarter and Full Year..
29/1/202417:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202415:13EDGAR2Form 144 - Report of proposed sale of securities
08/1/202407:03EDGAR2Form 8-K - Current report
08/1/202407:00PRNUSBlueprint Medicines Highlights 2024 Corporate Strategy and..
05/1/202415:01PRNUSBlueprint Medicines Announces Inducement Grants Under Nasdaq..
26/12/202315:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/12/202315:09EDGAR2Form 144 - Report of proposed sale of securities
19/12/202315:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/12/202307:00PRNUSBlueprint Medicines to Present at 42nd Annual J.P. Morgan..
15/12/202315:23EDGAR2Form 144 - Report of proposed sale of securities
13/12/202314:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/12/202307:05PRNUSBlueprint Medicines' AYVAKYT® (avapritinib) Receives..
11/12/202316:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/12/202311:30PRNUSBlueprint Medicines' Leadership in Driving Continued..
07/12/202317:09EDGAR2Form 144 - Report of proposed sale of securities

Su Consulta Reciente

NASDAQ
BPMC
Blueprint Medicines
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados